These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy. Michaelides M; Stover NB; Francis PJ; Weleber RG Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626 [TBL] [Abstract][Full Text] [Related]
4. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice. Browning DJ Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706 [TBL] [Abstract][Full Text] [Related]
5. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging. Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202 [TBL] [Abstract][Full Text] [Related]
6. Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy. Lai TY; Ngai JW; Chan WM; Lam DS Doc Ophthalmol; 2006 May; 112(3):177-87. PubMed ID: 16804707 [TBL] [Abstract][Full Text] [Related]
7. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography. Lyons JS; Severns ML Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914 [TBL] [Abstract][Full Text] [Related]
8. Early paracentral visual field loss in patients taking hydroxychloroquine. Elder M; Rahman AM; McLay J Arch Ophthalmol; 2006 Dec; 124(12):1729-33. PubMed ID: 17159032 [TBL] [Abstract][Full Text] [Related]
9. Retinal toxicity in long term hydroxychloroquine treatment. Mavrikakis M; Papazoglou S; Sfikakis PP; Vaiopoulos G; Rougas K Ann Rheum Dis; 1996 Mar; 55(3):187-9. PubMed ID: 8712882 [TBL] [Abstract][Full Text] [Related]
15. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy. Leung LS; Neal JW; Wakelee HA; Sequist LV; Marmor MF Am J Ophthalmol; 2015 Oct; 160(4):799-805.e1. PubMed ID: 26189086 [TBL] [Abstract][Full Text] [Related]
16. Hydroxychloroquine therapy in massive total doses without retinal toxicity. Johnson MW; Vine AK Am J Ophthalmol; 1987 Aug; 104(2):139-44. PubMed ID: 3618711 [TBL] [Abstract][Full Text] [Related]
17. Retinopathy and antimalarial drugs--the British experience. Spalton DJ Lupus; 1996 Jun; 5 Suppl 1():S70-2. PubMed ID: 8803916 [TBL] [Abstract][Full Text] [Related]
18. Long-term course of chloroquine retinopathy after cessation of medication. Brinkley JR; Dubois EL; Ryan SJ Am J Ophthalmol; 1979 Jul; 88(1):1-11. PubMed ID: 463998 [TBL] [Abstract][Full Text] [Related]
20. [Supervision of the eyes during prolonged treatment with synthetic antimalarial drugs. Results in 237 patients followed up for 4 years on the average]. Bertrand JJ; Debeyre N; Kahn MF; Ryckewaert A Presse Med (1893); 1968 Nov; 76(45):2139-42. PubMed ID: 5720115 [No Abstract] [Full Text] [Related] [Next] [New Search]